MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ejhf.2316

Медицинская библиотека · European journal of heart failure · 2021

Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation.

Caiffa Thomas, De Luca Antonio, Biagini Elena, Lupi Laura, Bedogni Francesco, Castrichini Matteo, Compagnone Miriam, Tusa Maurizio, Berardini Alessandra, Merlo Marco, Fabris Enrico, Popolo Rubbio Antonio, Tomasoni Daniela, Di Pasquale Mattia, Arosio Roberto, Perkan Andrea, Barbati Giulia, Saia Francesco, Adamo Marianna, Stolfo Davide, Sinagra Gianfranco

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

AIMS: In patients with heart failure and reduced ejection fraction (HFrEF) and secondary mitral regurgitation (SMR), impaired right ventricular function (RVF) may negatively influence the prognosis. Percutaneous mitral valve repair (pMVR) can promote the recovery of RVF. We sought to characterize the response of the right ventricle to pMVR in HFrEF with SMR and to assess the association between improved RVF after pMVR and outcomes.

METHODS AND

RESULTS

Overall, 221 patients with HFrEF and SMR ≥3+ successfully treated with pMVR in four tertiary care centres for heart failure were included. Improved RVF was defined as Δ right ventricular fractional area change (ΔRVFAC) ≥5% at early follow-up (median time 4 months). The primary endpoint was a composite of death/heart transplantation (D/HT). Mean age was 69 ± 11 years, mean left ventricular ejection fraction was 31 ± 8% and mean RVFAC was 34 ± 9%. ΔRVFAC ≥5% occurred in 88 patients (40%) and was independent of the measures of left ventricular reverse remodelling. During a median follow-up of 29 months (interquartile range 12-46), 81 patients (37%) reached the primary endpoint. After adjustment for other significant covariates, ΔRVFAC ≥5% was significantly associated with lower risk of D/HT (hazard ratio 0.52, 95% confidence interval 0.29-0.94, P = 0.030). In the secondary outcome analysis exploring the risk of heart failure hospitalizations, ΔRVFAC ≥5% confirmed the prognostic association with the endpoint.

CONCLUSIONS

In patients with HFrEF and SMR, about 40% of patients improved RVF after pMVR. RVF improvement was associated with better long-term survival free from HT and lower risk of heart failure hospitalization.

Для цитирования: Caiffa Thomas, De Luca Antonio, Biagini Elena, Lupi Laura, Bedogni Francesco, Castrichini Matteo, Compagnone Miriam, Tusa Maurizio, Berardini Alessandra, Merlo Marco, Fabris Enrico, Popolo Rubbio Antonio, Tomasoni Daniela, Di Pasquale Mattia, Arosio Roberto, Perkan Andrea, Barbati Giulia, Saia Francesco, Adamo Marianna, Stolfo Davide, Sinagra Gianfranco. Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation.. European journal of heart failure. 2021. DOI: 10.1002/ejhf.2316.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.